Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying

5/22/24 7:35:52 AM ET

$DUOT

$OCUP

Computer Software: Prepackaged Software

Technology

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $DUOT alert in real time by email

The Dow Jones index closed higher by 0.2% on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Bespoke Extracts

The Trade: Bespoke Extracts, Inc. (OTC:BSPK) CEO Michael Feinsod bought a total of 2,000 shares at an average price of $0.13. To acquire these shares, it cost around $268.
What's Happening: The company’s stock lost around 48% over the past six months.
What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.

Ocuphire Pharma

The Trade: Ocuphire Pharma, Inc. (NASDAQ:OCUP) CEO George Magrath acquired a total of 5,000 shares at an average price of $1.75. To acquire these shares, it cost around $8,773.
What's Happening: On May 10, Ocuphire Pharma posted a wider-than-expected quarterly loss.
What Ocuphire Pharma Does: Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.